Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATIP ATI Physical Therapy	$0.68	$0.83	$0.01 ▼ $6.59	$2.98M	-0.15	9,934 shs	10 shs
BBLG Bone Biologics	$2.20 +5.8%	$3.50	$2.08 ▼ $16.50	$1.19M	0.66	221,130 shs	63,808 shs
DFHT Deerfield Healthcare Technology Acquisitions	$0.02	$9.43	$9.90 ▼ $18.42	$331K	N/A	111,677 shs	6,097 shs
IVF INVO Fertility	$1.10 -22.0%	$2.61	$1.08 ▼ $51.12	$792K	1.99	889,622 shs	1.02 million shs

Analysts Agree—These Gold Picks Outshine the Rest

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATIP ATI Physical Therapy	0.00%	0.00%	-34.47%	-25.00%	-88.36%
BBLG Bone Biologics	-5.45%	-11.86%	-27.27%	-60.61%	-76.89%
DFHT Deerfield Healthcare Technology Acquisitions	0.00%	0.00%	0.00%	0.00%	0.00%
IVF INVO Fertility	-10.19%	-19.43%	-44.23%	-78.34%	-95.22%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ATIP ATI Physical Therapy	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
BBLG Bone Biologics	1.0162 of 5 stars	0.0	5.0	0.0	0.0	1.1	0.0	1.3
DFHT Deerfield Healthcare Technology Acquisitions	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
IVF INVO Fertility	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating	Consensus Price Target	% Upside from Current Price
ATIP ATI Physical Therapy	N/A	N/A	N/A
BBLG Bone Biologics	N/A	N/A	N/A
DFHT Deerfield Healthcare Technology Acquisitions	N/A	N/A	N/A
IVF INVO Fertility	N/A	N/A	N/A

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ATIP ATI Physical Therapy	$741.86M	0.00	$3.55 per share	0.19	($23.96) per share	-0.03
BBLG Bone Biologics	N/A	N/A	N/A	N/A	$8.39 per share	N/A
DFHT Deerfield Healthcare Technology Acquisitions	N/A	N/A	N/A	N/A	$0.28 per share	N/A
IVF INVO Fertility	$6.62M	0.12	N/A	N/A	($89.58) per share	-0.01

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ATIP ATI Physical Therapy	-$69.79M	-$19.42	N/A	∞	N/A	-7.79%	N/A	-3.87%	11/3/2025 (Estimated)
BBLG Bone Biologics	-$4.11M	N/A	0.00	N/A	N/A	N/A	-124.28%	-114.17%	N/A
DFHT Deerfield Healthcare Technology Acquisitions	-$21.51M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
IVF INVO Fertility	-$9.10M	-$93.14	N/A	∞	N/A	-422.11%	N/A	-81.50%	N/A

Latest DFHT, ATIP, BBLG, and IVF Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/14/2025	Q2 2025	BBLG Bone Biologics	-$0.58	-$1.33	-$0.75	-$1.33	N/A	N/A
8/14/2025	Q2 2025	IVF INVO Fertility	N/A	-$7.95	N/A	-$13.30	N/A	$1.86 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ATIP ATI Physical Therapy	N/A	N/A	N/A	N/A	N/A
BBLG Bone Biologics	N/A	N/A	N/A	N/A	N/A
DFHT Deerfield Healthcare Technology Acquisitions	N/A	N/A	N/A	N/A	N/A
IVF INVO Fertility	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ATIP ATI Physical Therapy	N/A	1.12	1.12
BBLG Bone Biologics	N/A	12.60	12.60
DFHT Deerfield Healthcare Technology Acquisitions	N/A	0.12	0.12
IVF INVO Fertility	N/A	0.08	0.07

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ATIP ATI Physical Therapy	72.60%
BBLG Bone Biologics	34.30%
DFHT Deerfield Healthcare Technology Acquisitions	89.54%
IVF INVO Fertility	12.02%

Insider Ownership

Company	Insider Ownership
ATIP ATI Physical Therapy	3.30%
BBLG Bone Biologics	6.10%
DFHT Deerfield Healthcare Technology Acquisitions	N/A
IVF INVO Fertility	0.57%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ATIP ATI Physical Therapy	5,600	4.41 million	4.27 million	No Data
BBLG Bone Biologics	2	545,000	504,000	Not Optionable
DFHT Deerfield Healthcare Technology Acquisitions	N/A	17.97 million	N/A	Not Optionable
IVF INVO Fertility	25	720,000	716,000	No Data

DFHT, ATIP, BBLG, and IVF Headlines

Recent News About These Companies

INVO Fertility, Inc.: INVO Fertility Announces Second Quarter 2025 Financial Results

August 15, 2025 | finanznachrichten.de

INVO Fertility Announces Second Quarter 2025 Financial Results

August 14, 2025 | globenewswire.com

INVO Fertility’s Recent Unregistered Equity Sale

August 9, 2025 | theglobeandmail.com

INVO Fertility Implements Reverse Stock Split

July 24, 2025 | theglobeandmail.com

INVO Fertility Announces First Quarter 2025 Financial Results

May 20, 2025 | globenewswire.com

INVO Fertility To Begin Trading Under New Nasdaq Ticker Symbol 'IVF'

April 26, 2025 | nasdaq.com

Sarasota fertility company changes name, ticker symbol

April 26, 2025 | businessobserverfl.comB

NAYA Biosciences spins off cancer drug business 6 months after INVO merger

April 15, 2025 | fiercebiotech.comF

NAYA Biosciences to separate fertility and oncology businesses into distinct operations, changes name to INVO Fertility

April 15, 2025 | msn.com

NAYA Biosciences announces strategic decision to separate fertility and oncology

April 15, 2025 | markets.businessinsider.com

NAYA Biosciences Changes Name to INVO Fertility Amid Business Separation

April 14, 2025 | marketwatch.com

NAYA Biosciences Inc trading halted, news pending

March 18, 2025 | markets.businessinsider.com

NAYA Biosciences to effect 1-for-12 reverse split

March 13, 2025 | markets.businessinsider.com

NAYA Biosciences supports executive order on fertility treatment access

February 26, 2025 | markets.businessinsider.com

Lakewood Ranch life sciences firm seeks to raise $9.5M through public offering

January 13, 2025 | businessobserverfl.comB

NAYA Biosciences To Raise $9.5 Mln Through Public Offering Of Units

January 13, 2025 | markets.businessinsider.com

NAYA Biosciences to present insights into mode of action of NY-303

November 1, 2024 | markets.businessinsider.com

NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma

October 24, 2024 | globenewswire.com

NAYA Biosciences Inc (INVO)

October 23, 2024 | investing.com

INVO Bioscience changes name, trading symbol after merger

October 22, 2024 | businessobserverfl.comB

New MarketBeat Followers Over Time

Media Sentiment Over Time

DFHT, ATIP, BBLG, and IVF Company Descriptions

ATI Physical Therapy NYSE:ATIP

$0.68 0.00 (0.00%)

As of 07/31/2025

ATI Physical Therapy, Inc. operates as an outpatient physical therapy provider that specializes in outpatient rehabilitation and adjacent healthcare services in the United States. It offers a range of services to its patients, including physical therapy to treat spine, shoulder, knee, and neck injuries or pain; work injury rehabilitation services, work conditioning and work hardening; and hand therapy, aquatic therapy, functional capacity evaluation, sports medicine, and wellness programs. It also provides ATI worksite solutions comprising injury prevention programs, work-related injury assessment services, wellness offerings, and consultations for employers; proprietary electronic medical records (EMR) integration, caseload management, and continuing education in therapy treatments; and sports medicine, including on-site sports physical therapy, clinical evaluation and diagnosis, immediate and emergency care, nutrition programs, and concussion management services. The company offers outpatient physical therapy services under the ATI brand name. ATI Physical Therapy, Inc. was founded in 1996 and is based in Bolingbrook, Illinois.

Bone Biologics NASDAQ:BBLG

$2.20 +0.12 (+5.77%)

As of 03:15 PM Eastern

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

Deerfield Healthcare Technology Acquisitions NASDAQ:DFHT

Deerfield Healthcare Technology Acquisitions Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare or healthcare-related industries in the United States and other developed countries. The company was incorporated in 2020 and is based in New York, New York.

INVO Fertility NASDAQ:IVF

$1.10 -0.31 (-21.99%)

As of 02:59 PM Eastern

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time